Abstract
Acute hyperglycemia during acute myocardial infarction is associated with worse myocardial injury and increased mortality. Using a mouse model of myocardial ischemia/reperfusion injury, we tested the hypothesis that acute hyperglycemia activates splenic leukocytes and subsequently exacerbates myocardial infarct size. We then examined whether the adverse effects of hyperglycemia could be attenuated by a potent anti-inflammatory agent (an agonist of the adenosine A2A receptor) administered immediately prior to reperfusion. C57BL6 (WT) mice underwent 30-min LAD occlusion and 60-min reperfusion with or without prior splenectomy. Acute hyperglycemia before ischemia increased myocardial infarct size (IS) by 43 % (p < 0.05). Splenectomy before ischemia did not change IS (vs. control, p = NS) but did serve to prevent the exacerbation of IS by hyperglycemia. Acute hyperglycemia activated splenic leukocytes by increasing formyl peptide receptor expression and reactive oxygen species production before ischemia, and enhanced splenic neutrophil release with resultant peripheral neutrophilia and increased myocardial neutrophil infiltration during reperfusion. Acute adoptive transfer of splenic leukocytes to splenectomized mice before ischemia restored the hyperglycemic exacerbation of infarct size. ATL146e, an adenosine 2A receptor (A2AR) agonist, abolished neutrophilia during reperfusion and reduced IS in hyperglycemic mice. ATL146e also reduced IS in splenectomized hyperglycemic mice with transfer of WT splenic leukocytes, but not with transfer of splenic leukocytes from A2AR knockout mice. Acute hyperglycemia prior to myocardial ischemia and reperfusion exacerbates IS by activating splenic leukocytes. ATL146e administered at reperfusion suffices to abrogate the hyperglycemic exacerbation of IS by acting on A2ARs on splenic leukocytes.
Similar content being viewed by others
References
Albacker T, Carvalho G, Schricker T, Lachapelle K (2008) High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. Ann Thorac Surg 86:20–27. doi:10.1016/j.athoracsur.2008.03.046
Bhamidipati CM, LaPar DJ, Stukenborg GJ, Morrison CC, Kern JA, Kron IL, Ailawadi G (2011) Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 141:543–551. doi:10.1016/j.jtcvs.2010.10.005
Bodi V, Sanchis J, Nunez J, Rumiza E, Mainar L, Lopez-Lereu MP, Monmeneu JV, Oltra R, Forteza MJ, Chorro FJ, Llacer A (2009) Post-reperfusion lymphopenia and microvascular obstruction in ST-segment elevation acute myocardial infarction. Rev Esp Cardiol 62:1109–1117. doi:10.1016/S1885-5857(09)73325-0
Celik T (2009) Glucose-insulin-potassium infusion in the management of acute hyperglycemia in patients with ST-segment elevation acute myocardial infarction: lessons learned from randomized trials. J Cardiol 54:167–168. doi:10.1016/j.jjcc.2009.02.015 (Author reply 168)
Chakrabarti AK, Singh P, Gopalakrishnan L, Kumar V, Elizabeth Doherty M, Abueg C, Wang W, Gibson CM (2012) Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics. Cardiol Res Pract. doi:10.1155/2012/704314
Coquery CM, Loo W, Buszko M, Lannigan J, Erickson LD (2012) Optimized protocol for the isolation of spleen-resident murine neutrophils. Cytom A 81:806–814. doi:10.1002/cyto.a.22096
Deckers JW, van Domburg RT, Akkerhuis M, Nauta ST (2013) Relation of admission glucose levels, short- and long-term (20-year) mortality after acute myocardial infarction. Am J Cardiol 112:1306–1310. doi:10.1016/j.amjcard.2013.06.007
Djordjevic-Radojkovic D, Koracevic G, Stanojevic D, Damjanovic M, Apostolovic S, Pavlovic M (2013) Stress hyperglycemia in acute ST-segment elevation myocardial infarction is a marker of left ventricular remodeling. Acute Card Care 15:38–43. doi:10.3109/17482941.2013.781190
Ekmekci A, Uluganyan M, Tufan F, Uyarel H, Karaca G, Kul S, Gungor B, Ertas G, Erer B, Sayar N, Gul M, Eren M (2013) Impact of admission blood glucose levels on prognosis of elderly patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention. J Geriatr Cardiol 10:310–316. doi:10.3969/j.issn.1671-5411.2013.04.002
Fu H, Bjorkman L, Janmey P, Karlsson A, Karlsson J, Movitz C, Dahlgren C (2004) The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide. BMC Cell Biol 5:50. doi:10.1186/1471-2121-5-50
Harada N, Okajima K, Murakami K, Usune S, Sato C, Ohshima K, Katsuragi T (2000) Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J Pharmacol Exp Ther 294:1034–1042
Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, Umemura T, Nakamura S, Yoshida M (2003) Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction. Am J Cardiol 92:288–291. doi:10.1016/S0002-9149(03)00627-1
Jugdutt BI, Menon V (2002) Beneficial effects of therapy on the progression of structural remodeling during healing after reperfused and nonreperfused myocardial infarction: different effects on different parameters. J Cardiovasc Pharmacol Ther 7:95–107. doi:10.1177/107424840200700206
Jung K, Kim P, Leuschner F, Gorbatov R, Kim JK, Ueno T, Nahrendorf M, Yun SH (2013) Endoscopic time-lapse imaging of immune cells in infarcted mouse hearts. Circ Res 112:891–899. doi:10.1161/CIRCRESAHA.111.300484
Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR (2002) Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology 96:183–188. doi:10.1097/00000542-200201000-00032
Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC (2000) Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 278:H1218–H1224
Kilpatrick EL, Narayan P, Mentzer RM Jr, Lasley RD (2002) Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization. Am J Physiol Heart Circ Physiol 282:H1035–H1040. doi:10.1152/ajpheart.00808.2001
Kummer U, Zobeley J, Brasen JC, Fahmy R, Kindzelskii AL, Petty AR, Clark AJ, Petty HR (2007) Elevated glucose concentrations promote receptor-independent activation of adherent human neutrophils: an experimental and computational approach. Biophys J 92:2597–2607. doi:10.1529/biophysj.106.086769
Leuschner F, Panizzi P, Chico-Calero I, Lee WW, Ueno T, Cortez-Retamozo V, Waterman P, Gorbatov R, Marinelli B, Iwamoto Y, Chudnovskiy A, Figueiredo JL, Sosnovik DE, Pittet MJ, Swirski FK, Weissleder R, Nahrendorf M (2010) Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res 107:1364–1373. doi:10.1161/CIRCRESAHA.110.227454
Ma Y, Yabluchanskiy A, Lindsey ML (2013) Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair 6:11. doi:10.1186/1755-1536-6-11
Mandal P, Novotny M, Hamilton TA (2005) Lipopolysaccharide induces formyl peptide receptor 1 gene expression in macrophages and neutrophils via transcriptional and posttranscriptional mechanisms. J Immunol 175:6085–6091. doi:10.4049/jimmunol.175.9.6085
Marala RB, Mustafa SJ (1998) Immunological characterization of adenosine A2A receptors in human and porcine cardiovascular tissues. J Pharmacol Exp Ther 286:1051–1057
Marfella R, D’Amico M, Di Filippo C, Piegari E, Nappo F, Esposito K, Berrino L, Rossi F, Giugliano D (2002) Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 45:1172–1181. doi:10.1007/s00125-002-0882-x
Marfella R, Di Filippo C, Portoghese M, Ferraraccio F, Rizzo MR, Siniscalchi M, Musacchio E, D’Amico M, Rossi F, Paolisso G (2009) Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J Am Coll Cardiol 53:1425–1436. doi:10.1016/j.jacc.2009.01.041
Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C, Portoghese M, Siciliano S, Nappo F, Sasso FC, Mininni N, Cacciapuoti F, Lucivero G, Giunta R, Verza M, Giugliano D (2003) Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 26:3129–3135. doi:10.2337/diacare.26.11.3129
Matyal R, Sakamuri S, Huang T, Owais K, Parikh S, Khabbaz K, Wang A, Sellke F, Mahmood F (2014) Oxidative stress and nerve function after cardiopulmonary bypass in patients with diabetes. Ann Thorac Surg. doi:10.1016/j.athoracsur.2014.06.041
Myant KB, Cammareri P, McGhee EJ, Ridgway RA, Huels DJ, Cordero JB, Schwitalla S, Kalna G, Ogg EL, Athineos D, Timpson P, Vidal M, Murray GI, Greten FR, Anderson KI, Sansom OJ (2013) ROS production and NF-kappaB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell 12:761–773. doi:10.1016/j.stem.2013.04.006
Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916–920. doi:10.1038/414916a
Panaro MA, Acquafredda A, Sisto M, Lisi S, Maffione AB, Mitolo V (2006) Biological role of the N-formyl peptide receptors. Immunopharmacol Immunotoxicol 28:103–127. doi:10.1080/08923970600625975
Pesaro AE, Nicolau JC, Serrano CV Jr, Truffa R, Gaz MV, Karbstein R, Giraldez RR, Kalil Filho R, Ramires JA (2009) Influence of leukocytes and glycemia on the prognosis of patients with acute myocardial infarction. Arq Bras Cardiol 92:84–93
Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, Comerma L, Chorny A, Shan M, Xu W, Magri G, Knowles DM, Tam W, Chiu A, Bussel JB, Serrano S, Lorente JA, Bellosillo B, Lloreta J, Juanpere N, Alameda F, Baro T, de Heredia CD, Toran N, Catala A, Torrebadell M, Fortuny C, Cusi V, Carreras C, Diaz GA, Blander JM, Farber CM, Silvestri G, Cunningham-Rundles C, Calvillo M, Dufour C, Notarangelo LD, Lougaris V, Plebani A, Casanova JL, Ganal SC, Diefenbach A, Arostegui JI, Juan M, Yague J, Mahlaoui N, Donadieu J, Chen K, Cerutti A (2012) B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 13:170–180. doi:10.1038/ni.2194
Raiden S, Nahmod K, Nahmod V, Semeniuk G, Pereira Y, Alvarez C, Giordano M, Geffner JR (2002) Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome. J Pharmacol Exp Ther 303:45–51. doi:10.1124/jpet.102.037382
Save S, Mohlin C, Vumma R, Persson K (2011) Activation of adenosine A2A receptors inhibits neutrophil transuroepithelial migration. Infect Immun 79:3431–3437. doi:10.1128/IAI.05005-11
Schofield ZV, Woodruff TM, Halai R, Wu MC, Cooper MA (2013) Neutrophils—a key component of ischemia-reperfusion injury. Shock 40:463–470. doi:10.1097/SHK.0000000000000044
Shay T, Jojic V, Zuk O, Rothamel K, Puyraimond-Zemmour D, Feng T, Wakamatsu E, Benoist C, Koller D, Regev A, ImmGen C (2013) Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc Natl Acad Sci USA 110:2946–2951. doi:10.1073/pnas.1222738110
Shore S, Borgerding JA, Gylys-Colwell I, McDermott K, Ho PM, Tillquist MN, Lowy E, McGuire DK, Stolker JM, Arnold SV, Kosiborod M, Maddox TM (2014) Association between hyperglycemia at admission during hospitalization for acute myocardial infarction and subsequent diabetes: insights From the Veterans Administration Cardiac Care Follow-up Clinical Study. Diabetes Care 37:409–418. doi:10.2337/dc13-1125
Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325:612–616. doi:10.1126/science.1175202
Szekely A, Levin J, Miao Y, Tudor IC, Vuylsteke A, Ofner P, Mangano DT, Investigators of the Multicenter Study of Perioperative Ischemia Research G, the Ischemia R, Education F (2011) Impact of hyperglycemia on perioperative mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 142:430–437. doi:10.1016/j.jtcvs.2011.03.009
Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Kitabata H, Ino Y, Ishibashi K, Komukai K, Hirata K, Akasaka T (2012) Impact of stress hyperglycemia on myocardial salvage following successfully recanalized primary acute myocardial infarction. Circ J 76:2690–2696. doi:10.1253/circj.CJ-12-0303
Terlecki M, Bednarek A, Kawecka-Jaszcz K, Czarnecka D, Bryniarski L (2013) Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction. Kardiol Pol 71:260–267. doi:10.5603/KP.2013.0038
Vandervelde S, van Amerongen MJ, Tio RA, Petersen AH, van Luyn MJ, Harmsen MC (2006) Increased inflammatory response and neovascularization in reperfused vs. non-reperfused murine myocardial infarction. Cardiovasc Pathol 15:83–90. doi:10.1016/j.carpath.2005.10.006
Varani K, Gessi S, Dionisotti S, Ongini E, Borea PA (1998) [3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes. Br J Pharmacol 123:1723–1731. doi:10.1038/sj.bjp.0701758
Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL (2002) Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40:1748–1754. doi:10.1016/S0735-1097(02)02483-X
Walker EF (1999) Management of diabetes and hyperglycaemia during myocardial infarction: review of the literature. Intensive Crit Care Nurs 15:259–265. doi:10.1054/iccn.1999.1461
Wang Z, Ni J, Shao D, Liu J, Shen Y, Zhou L, Huang Y, Yu C, Wang J, Xue H, Lu L (2013) Elevated transcriptional co-activator p102 mediates angiotensin II type 1 receptor up-regulation and extracellular matrix overproduction in the high glucose-treated rat glomerular mesangial cells and isolated glomeruli. Eur J Pharmacol 702:208–217. doi:10.1016/j.ejphar.2013.01.031
Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, Marshall MA, French BA, Linden J (2006) Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation 114:2056–2064. doi:10.1161/CIRCULATIONAHA.106.649244
Yang Z, Laubach VE, French BA, Kron IL (2009) Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. J Thorac Cardiovasc Surg 137:723–729. doi:10.1016/j.jtcvs.2008.08.056
Yang Z, Linden J, Berr SS, Kron IL, Beller GA, French BA (2008) Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI. Am J Physiol Heart Circ Physiol 295:H2328–H2335. doi:10.1152/ajpheart.00091.2008
Yang Z, Tian Y, Liu Y, Hennessy S, Kron IL, French BA (2013) Acute hyperglycemia abolishes ischemic preconditioning by inhibiting Akt phosphorylation: normalizing blood glucose before ischemia restores ischemic preconditioning. Oxid Med Cell Longev. doi:10.1155/2013/329183
Acknowledgments
This study was funded in part by University of Virginia Department of Surgery Startup Funds and University of Virginia School of Medicine Collaborative Science Pilot Grant to ZY and by NIH R01 HL 092305 to ILK and BAF.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tian, Y., French, B.A., Kron, I.L. et al. Splenic leukocytes mediate the hyperglycemic exacerbation of myocardial infarct size in mice. Basic Res Cardiol 110, 39 (2015). https://doi.org/10.1007/s00395-015-0496-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00395-015-0496-3